Daily BriefsSouth Korea

Daily Brief South Korea: Lotte Rental, Gabia Inc, Hanyang Eng and more

In today’s briefing:

  • Korea’s 4th Policy Trade Is Right Around the Corner: Mandatory Tender Offers
  • A Review of Tender Offers in Korea in 2025
  • Primer: Hanyang Eng (045100 KS) – Dec 2025


Korea’s 4th Policy Trade Is Right Around the Corner: Mandatory Tender Offers

By Sanghyun Park

  • The next policy swing is mandatory tender offers (MTO), with the gov’t + ruling party pushing for passage this session, likely alongside the mandatory treasury-share cancellation.
  • 2022 FSS/FSC 50%+1 trigger scrapped; 25% stays. Ruling party favors 50%+ MTO, base case 100%, but pushback may reduce to 70–80%.
  • MTOs tighten discounts, benefit minority holders; focus on local holding firms, PE-backed exits, and parent-driven M&A prospects.

A Review of Tender Offers in Korea in 2025

By Douglas Kim

  • In this insight, we review the major tender offers of Korean companies in 2025. Some of the major M&A tender offers in 2025 include HMM, Kolon Mobility Group, and VIOL.
  • The tender offers have mostly been profitable for the investors in these targeted companies (especially those shareholders who owned these shares prior to the tender offer announcement).
  • What is also impressive is that even after the 1st day of trading (post tender offer announcement), there have been extra alpha for the following week.

Primer: Hanyang Eng (045100 KS) – Dec 2025

By αSK

  • Hanyang Eng is a key enabler of the high-tech industry, specializing in the construction of facilities for semiconductor and display manufacturers, which positions it to benefit from the ongoing global investment in chip production.
  • The company demonstrates strong financial health, characterized by consistent revenue growth, robust profitability, and a strong dividend profile, making it an attractive value and income investment.
  • While heavily exposed to the cyclical nature of the semiconductor industry, Hanyang Eng is diversifying its business into bio-pharmaceuticals, aerospace, and green energy, potentially mitigating long-term risks and opening new growth avenues.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars